Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

69results about How to "High prevalence" patented technology

Biguanide and sulfonylurea formulations for the prevention and treatment of insulin resistance and type 2 diabetes mellitus

The invention describes formulations that include either metformin, sulfonylurea or a biguanide-sulfonylurea combination as one active ingredient in addition to specific, other active ingredients. The compositions and dosage forms of the invention are clinically useful as methods for increasing the effectiveness, efficiency and safety of the included biguanide (metformin) and / or sulfonylurea in the prevention and treatment of insulin resistance and diabetes mellitus. The carefully chosen additional active ingredients of the invention are designed in a modular fashion to prevent and rectify adverse events associated with insulin resistance syndrome and diabetes mellitus, and those adverse incidences associated with the concurrent use of metformin and / or the sulfonylureas. When clinically administered, the invention will provide therapeutic levels of metformin and of a sulfonylurea, alone or in combination, and broaden their usefulness. The invention will retard the progression of insulin resistance to type 2 diabetes, and reduce the serious microvascular and macrovascular complications commonly associated with insulin resistance syndrome and diabetes mellitus.
Owner:CHRONORX

Methods and systems for utilizing quantitative imaging

Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties / analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties / analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
Owner:ELUCID BIOIMAGING INC

Methods and systems for utilizing quantitative imaging

Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties / analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties / analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
Owner:ELUCID BIOIMAGING INC

System and method for testing multiple dial-up points in a communications network

A monitoring station system and method for monitoring multiple dial-up points in a communications network, such as an Internet or intranet site. A single monitoring station runs dial monitor processes that can concurrently establish connections to, and test multiple dial-up points of, the site. Test data regarding availability and response time of the dial-up points can be obtained. Additionally, a transaction monitor process may run as a parent process of the dial monitor processes. The transaction monitor process provides service-specific monitors that use the established connections to the dial-up points to test services offered by, or via, the site, such as DHCP, HTTP and others. A different service of the site can be tested via each different connection. Specific testing is performed based on a profile that is tailored to customer needs. The connections may be established via analog modems, DSL modems, or ISDN terminal adapters / modems.
Owner:IBM CORP

Quantitative imaging for detecting histopathologically defined plaque fissure non-invasively

Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties / analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties / analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
Owner:ELUCID BIOIMAGING INC

Traditional Chinese medicine composition for treating chronic atrophic gastritis and intestinal metaplasia and preparation method and application thereof

ActiveCN105056128AMake clearDialectical and reasonableDigestive systemAluminium/calcium/magnesium active ingredientsGastric mucosal atrophyCodonopsis pilosula
The invention belongs to the field of pharmaceutical preparation, particularly discloses a traditional Chinese medicine composition for treating chronic atrophic gastritis and intestinal metaplasia and a preparation method and application thereof. The traditional Chinese medicine composition comprises the following raw materials: codonopsis pilosula, stir-fried rhizoma atractylodis macrocephalae, rhizoma pinellinae praeparata, poria cocos, pericarpium citri reticulatae, hedyotis diffusa, mica atba, rhizoma curcumae and radix curcumae; the preparation method comprises the steps of water extraction, alcohol precipitation, spray drying and addition of auxiliary materials, therefore various preparations are obtained, and the functions of invigorating spleen, supplementing qi, regulating qi-flowing for harmonizing stomach, and improving and resisting gastric mucosal atrophy and intestinal metaplasia are achieved, besides, the invention further discloses the application of the traditional Chinese medicine composition to preparation of drugs used for treating chronic atrophic gastritis and intestinal metaplasia.
Owner:JIANGSU PROVINCE INST OF TRADITIONAL CHINESE MEDICINE +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products